RD3 and neoplasm: In this direction, in vitro/in vivo gene manipulation studies coupled with knock-in/knock-out double transgenic approaches are currently underway in our laboratory to pinpoint the role of RD3 loss in tumor invasion, metastasis, and neuroblastoma progression.